---
title: 'Treatment exit options for non-infectious uveitis registry: participant characteristics
  at 3 years'
date: '2024-06-10'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38857972/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240611181022&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSIONS: Less than half of participants required DMARD treatment
  at baseline, with csDMARDs used more frequently than bDMARDs. The presence of severe
  visual impairment was low, mostly affecting patients with panuveitis. These findings
  are in line with comparable monocentric cross-sectional studies of tertiary uveitis
  centres in Germany and will allow us to generate generalisable evidence in ...'
disable_comments: true
---
CONCLUSIONS: Less than half of participants required DMARD treatment at baseline, with csDMARDs used more frequently than bDMARDs. The presence of severe visual impairment was low, mostly affecting patients with panuveitis. These findings are in line with comparable monocentric cross-sectional studies of tertiary uveitis centres in Germany and will allow us to generate generalisable evidence in ...